EndoStim officially spikes $35m IPO
EndoStim today officially spiked an initial public offering it hoped would raise $35 million for its neurostimulation device for gastroesophageal reflux disease.
EndoStim, which had planned to put $10 million of the IPO’s proceeds into clinical studies and another $14 million to commercialize the system, tabled the offering in October 2014. Today the company filed a formal withdrawal request with the U.S. Securities & Exchange Commission, citing “market conditions.”
EndoStim is operating from a small headquarters in St. Louis where it employs 13 people, including CEO Bevil Hogg, who took Stereotaxis (N...
Source: Mass Device - December 9, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Initial Public Offering (IPO) Funding Roundup EndoStim Source Type: news
Generic Pill Blocked in U.S. Over Its Color
Dr. Reddy’s has been blocked from selling its generic version of the heartburn drug Nexium in the U.S., after AstraZeneca objected to the pill’s purple color. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 11, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news
U.S. court imposes temporary sales ban on Dr Reddy's generic Nexium
MUMBAI (Reuters) - Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said on Tuesday it had been temporarily barred by a U.S. court from selling its generic form of blockbuster heartburn drug Nexium in the United States. (Source: Reuters: Health)
Source: Reuters: Health - November 10, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Dr Reddy's restrained from selling generic drug Nexium in US market
Nexium is used to treat severe gastric diseases. The company said the order has been passed pending further hearing or trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 10, 2015 Category: Pharmaceuticals Source Type: news
Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT)
Source: NYT - October 15, 2015 Category: American Health Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news
Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT Health)
Source: NYT Health - October 15, 2015 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news
Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT)
Source: NYT - October 15, 2015 Category: Nutrition Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news
Sun Pharma withdraws lawsuit filed by Ranbaxy against USFDA
The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 9, 2015 Category: Pharmaceuticals Source Type: news
Dr Reddy's launches Nexium generic in US market
Drug major Dr Reddy's Laboratories (DRL) has launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 28, 2015 Category: Pharmaceuticals Source Type: news
Fast Relief For Heartburn
When heartburn hits, you need a fast and reliable way of dealing with the pain.
But before you take another antacid, or prescription like Nexium, Prilosec, or Prevacid, there’s something I want to share with you.
Heartburn drugs actually make your condition worse over time. And there’s new evidence they boost your risk of heart attack by up to 20%.
I know it’s frustrating to hear another prescription drug is doing terrible things to your body.
But today, I’ll show you a few options that will shut down heartburn almost immediately.
These options are safe, affordable, and easy to use.
Let m...
Source: Al Sears, MD Natural Remedies - July 17, 2015 Category: Complementary Medicine Authors: Andrew Britton Tags: Anti-Aging Source Type: news
esomeprazole (Nexium, Nexium 24HR, Nexium IV)
Title: esomeprazole (Nexium, Nexium 24HR, Nexium IV)Category: MedicationsCreated: 5/8/2001 12:00:00 AMLast Editorial Review: 6/30/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 30, 2015 Category: Drugs & Pharmacology Source Type: news
esomeprazole (Nexium, Nexium 24HR, Nexium IV)
Title: esomeprazole (Nexium, Nexium 24HR, Nexium IV)Category: MedicationsCreated: 5/8/2001 12:00:00 AMLast Editorial Review: 6/30/2015 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 30, 2015 Category: Nutrition Source Type: news
Data Dive Suggests Link Between Heartburn Drugs And Heart Attacks
The drugs are proton-pump inhibitors, including Prilosec, Nexium and Prevacid. But the study doesn't show cause and effect. Other factors — diet, drink or tobacco — may play a role.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - June 11, 2015 Category: Consumer Health News Authors: Richard Harris Source Type: news
Common heartburn drugs could raise risk of heart attacks
Millions of people take drugs known as proton pump inhibitors (PPIs) to treat heartburn and acid reflux. Popular brands include Prilosec, Prevacid and Nexium. But now a new study raises concern that they may increase the risk of heart attacks. Brian Webb reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 11, 2015 Category: Consumer Health News Source Type: news
Why Medicare's List Of Costly Drugs Is Kind Of Bogus
No, the most expensive drug for the U.S. Medicare drug benefit program is not Nexium, the heartburn medicine – no matter what Medicare says. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2015 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
